200 related articles for article (PubMed ID: 18845762)
1. Skeletal muscle differentiation of embryonic mesoangioblasts requires pax3 activity.
Messina G; Sirabella D; Monteverde S; Galvez BG; Tonlorenzi R; Schnapp E; De Angelis L; Brunelli S; Relaix F; Buckingham M; Cossu G
Stem Cells; 2009 Jan; 27(1):157-64. PubMed ID: 18845762
[TBL] [Abstract][Full Text] [Related]
2. Transgenic mice expressing PAX3-FKHR have multiple defects in muscle development, including ectopic skeletal myogenesis in the developing neural tube.
Finckenstein FG; Davicioni E; Osborn KG; Cavenee WK; Arden KC; Anderson MJ
Transgenic Res; 2006 Oct; 15(5):595-614. PubMed ID: 16952014
[TBL] [Abstract][Full Text] [Related]
3. Time-dependent Pax3-mediated chromatin remodeling and cooperation with Six4 and Tead2 specify the skeletal myogenic lineage in developing mesoderm.
Magli A; Baik J; Mills LJ; Kwak IY; Dillon BS; Mondragon Gonzalez R; Stafford DA; Swanson SA; Stewart R; Thomson JA; Garry DJ; Dynlacht BD; Perlingeiro RCR
PLoS Biol; 2019 Feb; 17(2):e3000153. PubMed ID: 30807574
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Pax3-expressing cells from adult blood vessels.
Goupille O; Pallafacchina G; Relaix F; Conway SJ; Cumano A; Robert B; Montarras D; Buckingham M
J Cell Sci; 2011 Dec; 124(Pt 23):3980-8. PubMed ID: 22159413
[TBL] [Abstract][Full Text] [Related]
5. Transcriptome analyses based on genetic screens for Pax3 myogenic targets in the mouse embryo.
Lagha M; Sato T; Regnault B; Cumano A; Zuniga A; Licht J; Relaix F; Buckingham M
BMC Genomics; 2010 Dec; 11():696. PubMed ID: 21143873
[TBL] [Abstract][Full Text] [Related]
6. Pax3:Foxc2 reciprocal repression in the somite modulates muscular versus vascular cell fate choice in multipotent progenitors.
Lagha M; Brunelli S; Messina G; Cumano A; Kume T; Relaix F; Buckingham ME
Dev Cell; 2009 Dec; 17(6):892-9. PubMed ID: 20059958
[TBL] [Abstract][Full Text] [Related]
7. Endoglin is required in Pax3-derived cells for embryonic blood vessel formation.
Young K; Krebs LT; Tweedie E; Conley B; Mancini M; Arthur HM; Liaw L; Gridley T; Vary C
Dev Biol; 2016 Jan; 409(1):95-105. PubMed ID: 26481065
[TBL] [Abstract][Full Text] [Related]
8. Pax3 and Tbx5 specify whether PDGFRα+ cells assume skeletal or cardiac muscle fate in differentiating embryonic stem cells.
Magli A; Schnettler E; Swanson SA; Borges L; Hoffman K; Stewart R; Thomson JA; Keirstead SA; Perlingeiro RC
Stem Cells; 2014 Aug; 32(8):2072-83. PubMed ID: 24677751
[TBL] [Abstract][Full Text] [Related]
9. Muscle stem cell behavior is modified by microRNA-27 regulation of Pax3 expression.
Crist CG; Montarras D; Pallafacchina G; Rocancourt D; Cumano A; Conway SJ; Buckingham M
Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13383-7. PubMed ID: 19666532
[TBL] [Abstract][Full Text] [Related]
10. Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations.
Ren YX; Finckenstein FG; Abdueva DA; Shahbazian V; Chung B; Weinberg KI; Triche TJ; Shimada H; Anderson MJ
Cancer Res; 2008 Aug; 68(16):6587-97. PubMed ID: 18701482
[TBL] [Abstract][Full Text] [Related]
11. Endothelial cell specification in the somite is compromised in Pax3-positive progenitors of Foxc1/2 conditional mutants, with loss of forelimb myogenesis.
Mayeuf-Louchart A; Montarras D; Bodin C; Kume T; Vincent SD; Buckingham M
Development; 2016 Mar; 143(5):872-9. PubMed ID: 26839363
[TBL] [Abstract][Full Text] [Related]
12. Smooth muscle of the dorsal aorta shares a common clonal origin with skeletal muscle of the myotome.
Esner M; Meilhac SM; Relaix F; Nicolas JF; Cossu G; Buckingham ME
Development; 2006 Feb; 133(4):737-49. PubMed ID: 16436625
[TBL] [Abstract][Full Text] [Related]
13. Functional dissection of Pax3 in paraxial mesoderm development and myogenesis.
Magli A; Schnettler E; Rinaldi F; Bremer P; Perlingeiro RC
Stem Cells; 2013 Jan; 31(1):59-70. PubMed ID: 23081715
[TBL] [Abstract][Full Text] [Related]
14. A Pax3/Dmrt2/Myf5 regulatory cascade functions at the onset of myogenesis.
Sato T; Rocancourt D; Marques L; Thorsteinsdóttir S; Buckingham M
PLoS Genet; 2010 Apr; 6(4):e1000897. PubMed ID: 20368965
[TBL] [Abstract][Full Text] [Related]
15. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts.
Sampaolesi M; Torrente Y; Innocenzi A; Tonlorenzi R; D'Antona G; Pellegrino MA; Barresi R; Bresolin N; De Angelis MG; Campbell KP; Bottinelli R; Cossu G
Science; 2003 Jul; 301(5632):487-92. PubMed ID: 12855815
[TBL] [Abstract][Full Text] [Related]
16. Mesoangioblasts from facioscapulohumeral muscular dystrophy display in vivo a variable myogenic ability predictable by their in vitro behavior.
Morosetti R; Gidaro T; Broccolini A; Gliubizzi C; Sancricca C; Tonali PA; Ricci E; Mirabella M
Cell Transplant; 2011; 20(8):1299-313. PubMed ID: 21176400
[TBL] [Abstract][Full Text] [Related]
17. Regulation of skeletal muscle stem cell behavior by Pax3 and Pax7.
Lagha M; Sato T; Bajard L; Daubas P; Esner M; Montarras D; Relaix F; Buckingham M
Cold Spring Harb Symp Quant Biol; 2008; 73():307-15. PubMed ID: 19022756
[TBL] [Abstract][Full Text] [Related]
18. Engraftment of mesenchymal stem cells into dystrophin-deficient mice is not accompanied by functional recovery.
Gang EJ; Darabi R; Bosnakovski D; Xu Z; Kamm KE; Kyba M; Perlingeiro RC
Exp Cell Res; 2009 Sep; 315(15):2624-36. PubMed ID: 19460366
[TBL] [Abstract][Full Text] [Related]
19. PAX3-FKHR induces morphological change and enhances cellular proliferation and invasion in rhabdomyosarcoma.
Anderson J; Ramsay A; Gould S; Pritchard-Jones K
Am J Pathol; 2001 Sep; 159(3):1089-96. PubMed ID: 11549601
[TBL] [Abstract][Full Text] [Related]
20. The transcriptional activator PAX3-FKHR rescues the defects of Pax3 mutant mice but induces a myogenic gain-of-function phenotype with ligand-independent activation of Met signaling in vivo.
Relaix F; Polimeni M; Rocancourt D; Ponzetto C; Schäfer BW; Buckingham M
Genes Dev; 2003 Dec; 17(23):2950-65. PubMed ID: 14665670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
